Figure 1.
Nelarabine-based therapies among patients with R/R T-ALL/LBL. ∗Three patients received Eto and CTX first at days 1 to 5 with nelarabine given at days 7 to 11; ∗∗2 of the 5 patients were also given Pegasparaginase 2500 U/m2 at day 22 and 1 patient was given vincristine 1.5 mg/m2 at days 22 and 29. CTX, cyclophosphamide; Eto, etoposide; 6MP, 6-mercaptopurine; ara-C, cytarabine; P-Asp, pegylated asparaginase.
